Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary Approaches to Multidisciplinary Pain Management.

Neurologic clinics·2025
Same author

Topical Analgesics.

Physical medicine and rehabilitation clinics of North America·2020
Same author

Pharmacologic Support in Pain Management.

Physical medicine and rehabilitation clinics of North America·2020
Same author

Opioid utilization patterns among patients with cancer and non-cancer pain.

Journal of opioid management·2019
Same author

A Systematic Assessment and Monitoring Intervention to Improve Pain Management and Quality Reporting Among Home Hospice Patients.

Journal of pain and symptom management·2018
Same author

Hospice Underutilization in the U.S.: The Misalignment of Regulatory Policy and Clinical Reality.

Journal of pain and symptom management·2018
Same journal

A Multicenter Randomized Pragmatic Trial Comparing Intra-Articular Injection, Genicular Nerve Block, and Radiofrequency Ablation for Knee Osteoarthritis Pain: SKOAP Phase 2 Protocol.

Pain medicine (Malden, Mass.)·2026
Same journal

Impact of Adjunctive Truncal Regional Analgesia on Postoperative Sleep Quality After Total Abdominal Hysterectomy: A Prospective Observational Study.

Pain medicine (Malden, Mass.)·2026
Same journal

Considerations for Cervical Medial Branch Nerve Radiofrequency at Spinal Motion Segments Adjacent to Cervical Fusion Constructs: A Technical Note.

Pain medicine (Malden, Mass.)·2026
Same journal

Return to work after neurostimulation for chronic pain: a systematic review and meta-analysis.

Pain medicine (Malden, Mass.)·2026
Same journal

AAPM Consensus Guidelines on Neuromodulation Technologies and Neurocomputer Interfaces for Pain Management and Functional Recovery.

Pain medicine (Malden, Mass.)·2026
Same journal

Painfully different numbers: Spinal patients' self-reported pain ratings in clinical versus research assessments.

Pain medicine (Malden, Mass.)·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

3.1K

NSAIDs supplement forward

Perry G Fine, Steven Stanos

    Pain Medicine (Malden, Mass.)
    |December 31, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
    06:14

    Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

    Published on: January 12, 2024

    2.7K
    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
    09:43

    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

    Published on: August 4, 2011

    17.5K

    Related Experiment Videos

    Last Updated: May 4, 2026

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
    08:56

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

    Published on: November 30, 2022

    3.1K
    Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
    06:14

    Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

    Published on: January 12, 2024

    2.7K
    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
    09:43

    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

    Published on: August 4, 2011

    17.5K